Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 3187
TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393659(US9969723, 41 | US9969723, 42)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393646(US9969723, 28)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393647(US9969723, 29)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393648(US9969723, 30)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393649(US9969723, 31)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393650(US9969723, 32)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393651(US9969723, 33)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393652(US9969723, 34)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393653(US9969723, 35)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393654(US9969723, 36)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393655(US9969723, 37 | US9969723, 38)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393655(US9969723, 37 | US9969723, 38)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393657(US9969723, 39)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393658(US9969723, 40)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393645(US9969723, 27)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393659(US9969723, 41 | US9969723, 42)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393661(US9969723, 43)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393662(US9969723, 44)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393663(US9969723, 45)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393664(US9969723, 46)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393665(US9969723, 47)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393666(US9969723, 48)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393667(US9969723, 49)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393668(US9969723, 50)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393669(US9969723, 51)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393670(US9969723, Comparative Example 1)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393671(US9969723, Comparative Example 2)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393632(US9969723, 14)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393620(US9969723, 2)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393621(US9969723, 3)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393622(US9969723, 4)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393623(US9969723, 5)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393624(US9969723, 6)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393625(US9969723, 7)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393626(US9969723, 8)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393627(US9969723, 9 | US9969723, 11)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393628(US9969723, 10)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393627(US9969723, 9 | US9969723, 11)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393630(US9969723, 12)
Affinity DataEC50: <200nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393631(US9969723, 13)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393618(US9969723, 1)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393633(US9969723, 15)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393634(US9969723, 16)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393635(US9969723, 17)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393636(US9969723, 18)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393637(US9969723, 19)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393638(US9969723, 20)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393639(US9969723, 21)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393640(US9969723, 22)
Affinity DataEC50: >300nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Hyundai Pharm

US Patent
LigandPNGBDBM393641(US9969723, 23)
Affinity DataEC50:  250nMAssay Description:The GPR40 protein activity according to the novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative of the present invention was measured by investi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: